Crescent Grove Advisors, LLC Zoetis Inc. Transaction History

Crescent Grove Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$145.48 - $175.02 $5,382 - $6,475	-37 Reduced 1.47%	2,479 $412,000
Q2 2022 Jul 20, 2022	SELL	$155.97 - $200.09 $8,266 - $10,604	-53 Reduced 2.06%	2,516 $432,000
Q1 2022 May 04, 2022	BUY	$181.39 - $234.03 $9,613 - $12,403	53 Added 2.11%	2,569 $484,000
Q3 2021 Oct 26, 2021	BUY	$189.29 - $209.69 $152,189 - $168,590	804 Added 46.96%	2,516 $488,000
Q2 2021 Jul 26, 2021	BUY	$155.9 - $187.99 $266,900 - $321,838	1,712 New	1,712 $319,000

1,921

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $84.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Crescent Grove Advisors, LLC with notifications on news.